辉瑞制药公司将以36亿美元协议收购君王制药公司，该公司主要生产止痛药。
Pfizer agreed to buy King Pharmaceuticals, a maker of pain remedies, for $3.6 billion.
本月美国辉瑞制药公司公布，美国食品及药品管理局(FDA)将加快抗癌药crizotinib的复审速度。
This month Pfizer, an American company, announced that America's Food and drug Administration (FDA) would speed up its review of a cancer drug called crizotinib.
思科公司(Cisco Systems)和辉瑞制药公司股价上涨0.6%，领涨道琼斯工业平均指数。
Cisco Systems Inc. and Pfizer Inc. were the biggest gainers in the Dow Jones Industrial Average, rising 0.6 percent each.
中国国家媒体报导，美国辉瑞制药公司在中国起诉两家公司复制辉瑞受欢迎的治疗男性阳萎的“威而钢”产品的案子中胜诉。
Chinese state media say U. S. drug maker Pfizer has won a court case in China against two companies which were copying its immensely popular male impotency treatment, Viagra.
根据此次提供的分别占45%和55%的现金加股票报价，辉瑞制药公司的股东将会持有合并后公司74%的股份，而阿斯利康制药公司的股东将会持有其余股份。
Based on the cash-and-stock offer, 45% and 55% respectively, Pfizer shareholders would hold 74% of the combined company while AstraZeneca shareholders would hold the remaining equity.
然而，辉瑞制药也名列众多宣布大量裁员的公司之中。
Pfizer was, however, among a number of companies that announced huge job cuts.
即使是比较保守性的行业，如制药业也深受其害：辉瑞公司计划解雇高达总雇员8%的研究员。
Even traditionally defensive industries, such as pharmaceuticals, are suffering: Pfizer plans to lay off up to 8% of its researchers.
数周来，关于全球最大的制药企业辉瑞公司，将会采取星爆式重组的方式进行拆分的猜测不绝于耳。
FOR weeks, speculation has been rife that Pfizer, the world's biggest pharmaceuticals company, will break itself into pieces, a restructuring move known as the starburst.
执全球制药业牛耳的辉瑞如今要裁员10,000人，占该公司全球员工的10%。
The world's biggest drugs firm is cutting 10,000 jobs, about a tenth of its global workforce.
辉瑞制药未来的拳头产品宣告失败，公司面临困境。
对于在全球税收体制下征税的公司，利用离岸金融中心将其税收降至最低的最直接的方法即是将资金送至海外并存放在那里，就如同辉瑞制药一样。
For companies taxed under the worldwide system, the most straightforward way to use OFCs to minimise taxes is to send money offshore and keep it there, as Pfizer did.
二月，世界最大的制药公司辉瑞制药有限公司宣布大幅缩减研究预算，其中受到影响的项目就包括抗生素相关项目。
In February Pfizer, the world's biggest drug company, announced deep cuts in its research budget. Among the programmes affected is the company's antibiotics effort.
抗癌药物曾一度不被诸如辉瑞制药等的大型制药公司看好。
Cancer was once unattractive for big pharmaceutical companies like Pfizer.
辉瑞和其它大制药公司一样都面临着非专利药的威胁，辉瑞公司正进行战略性收缩和重塑。
Like many big pharmas facing a generics threat, Pfizer is slimming down and restructuring.
该公司在今天的一份声明中透露，自2006年以来，董事会推举瑞德（57岁）负责辉瑞全球生物制药业务。
Read, 5 []7, the head of Pfizer’s global biopharmaceutical operations since 2006, was elected by the board, the New York- based company said in a statement today.
美国的一家制药公司，辉瑞正在安排7500万美元赔偿卡诺州北部城市的原告们。
Pfizer, an American drugs company, is arranging details of a $75m payout to plaintiffs in the northern city of Kano.
辉瑞公司上周宣布，已与罗氏和Alnylam一道，就这种形式的RNAi药物运输工具与加拿大生物技术Tekmira制药公司达成一笔交易。
Pfizer last week announced a deal with Canadian biotech Tekmira Pharmaceuticals Corp for this type of delivery vehicle for its RNAi drugs, joining Roche and Alnylam.
在3月份，辉瑞还宣布剥离4个非制药子公司以专注于它的核心业务。
In March, Pfizer also announced a strategy to spin off four non-pharma units to focus on its core business.
最引人注目的交易都与辉瑞（Pfizer）【译注10】有关联，这家保守的药业巨头同突然发迹的仿制药公司之间的惬意合作并不为人熟知。
The most striking deals have involved Pfizer, a conservative giant not known for cosiness with upstart generics firms.
辉瑞2005 年向这两家公司提出起诉．中国地方制药公司已经加大了对专利的挑战，希望获准出售各种药品的复制品。
Pfizer sued the two companies in 2005. Local drug makers have stepped up patent challenges in hopes of being allowed to market generic copies of various drugs.
许多分析师预测辉瑞可能为新药而吞并小的制药公司。
Many analysts predict that Pfizer will try to acquire smaller companies for new drugs.
在中国开展药物研究的其他主要制药公司包括诺华，阿斯利康，辉瑞，葛兰素史克和罗氏。
Other major drug companies with a research presence in China include Novartis AG, AstraZeneca Plc, Pfizer inc., GlaxoSmithKline and Roche Holding AG.
包括辉瑞和默克在内的美国公司试图在专利到期前几个月推出自己的“授权仿制药”，以减轻仿制药带来的竞争影响。
American firms, including Pfizer and Merck, are trying to launch their own "authorised generics" a few months before patents expire to try to blunt the impact of competition.
但是，包括辉瑞制药在内的外国公司则多次呼吁中国加强对专利、版权和商标的保护。
But foreign companies including Pfizer have repeatedly called on China to tighten patent protections, Copyrights and trademarks.
辉瑞公司成立于1849年，是以研发为基础的全球最大的制药公司之一。
Pfizer Inc, founded in 1849, is one of the largest research-based pharmaceutical companies in the world.
辉瑞，全球最大以研发为基础的生物制药公司之一，创建于1849年，迄今已有160多年的历史。
Pfizer, founded in 1849, is the one of the world's largest biological pharmaceutical companybased onresearch and development withs a long history of more than 160 years.
辉瑞公司成立于1849年，是以研发为基础的全球最大的制药公司之一。
Inc, founded in 1849, is one of the largest research-based pharmaceutical companies in the world.
辉瑞公司是全球最大的生物制药公司。
辉瑞是世界领先的生物制药公司。
伊恩阅读，现任全球制药业务在辉瑞公司，预计将成为集团总裁辉瑞生物制药企业。
Ian Read, now president of global pharmaceutical operations at Pfizer, is slated to become group president of Pfizer BioPharmaceutical Businesses.
应用推荐